Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Bergentoft Pharma Consulting AB

Closing information (x1000 EUR)

Closing information 2023/12 2022/12 2021/12
Turnover 179 More Arrow 185 Less Arrow 115
Financial expenses 1 Less Arrow 0 Equal arrow 0
Earnings before taxes 156 Less Arrow 114 Less Arrow 79
EBITDA 155 Less Arrow 114 Less Arrow 79
Total assets 359 Less Arrow 264 Less Arrow 166
Current assets 273 Less Arrow 174 Less Arrow 166
Current liabilities 56 More Arrow 69 Less Arrow 40
Equity capital 280 Less Arrow 181 Less Arrow 118
- share capital 5 Less Arrow 4 More Arrow 5
Employees (average) 2 Less Arrow 1 Equal arrow 1

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 78.0% Less Arrow 68.6% More Arrow 71.1%
Turnover per employee 90 More Arrow 185 Less Arrow 115
Profit as a percentage of turnover 87.2% Less Arrow 61.6% More Arrow 68.7%
Return on assets (ROA) 43.7% Less Arrow 43.2% More Arrow 47.6%
Current ratio 487.5% Less Arrow 252.2% More Arrow 415.0%
Return on equity (ROE) 55.7% More Arrow 63.0% More Arrow 66.9%
Change turnover -6 More Arrow 79 Less Arrow 55
Change turnover % -3% More Arrow 75% More Arrow 91%
Chg. No. of employees 1 Less Arrow 0 Equal arrow 0
Chg. No. of employees % 100% Less Arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.